Advertisement
Screener

Lite Strategy, Inc. (LITS) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Lite Strategy, Inc. Investing Cash Flow

Lite Strategy, Inc. (LITS) reported Investing Cash Flow of -$97.33 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-13

  • Lite Strategy, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $2.10M.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $569.00K, a 97.22% decline year-over-year.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$100.00M, a 780.41% decline year-over-year.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $35.15M, a 28.47% decline from fiscal 2024.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $49.14M, a 8.47% decline from fiscal 2023.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $53.69M, a 679.02% increase from fiscal 2022.
  • Lite Strategy, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $6.89M, a 72.11% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 monthNet Cash Provided by (Used in) Investing Activities 130 monthNet Cash Provided by (Used in) Investing Activities 133 monthNet Cash Provided by (Used in) Investing Activities 136 monthNet Cash Provided by (Used in) Investing Activities 139 monthNet Cash Provided by (Used in) Investing Activities 142 monthNet Cash Provided by (Used in) Investing Activities 145 monthNet Cash Provided by (Used in) Investing Activities 148 monthNet Cash Provided by (Used in) Investing Activities 151 monthNet Cash Provided by (Used in) Investing Activities 154 monthNet Cash Provided by (Used in) Investing Activities 157 month
2026-03-31$2.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13
$2.67M
derived: sum of 2 quarters · filed 2026-05-13
-$97.33M
10-Q · filed 2026-05-13
-$97.33M
derived: sum of 4 quarters · filed 2026-05-13
2025-12-31$569.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17
-$99.43M
10-Q · filed 2026-02-17
-$99.43M
derived: sum of 3 quarters · filed 2026-02-17
-$99.43M
derived: sum of 4 quarters · filed 2026-05-13
2025-09-30-$100.00M
10-Q · filed 2025-11-14
-$100.00M
derived: sum of 2 quarters · filed 2025-11-14
-$100.00M
derived: sum of 3 quarters · filed 2026-05-13
-$79.55M
derived: sum of 4 quarters · filed 2026-05-13
2025-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26
$0.00
derived: sum of 2 quarters · filed 2026-05-13
$20.45M
derived: sum of 3 quarters · filed 2026-05-13
$35.15M
10-K · filed 2025-09-26
2025-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13
$20.45M
derived: sum of 2 quarters · filed 2026-05-13
$35.15M
10-Q · filed 2026-05-13
$54.69M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$20.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17
$35.15M
10-Q · filed 2026-02-17
$54.69M
derived: sum of 3 quarters · filed 2026-02-17
$54.82M
derived: sum of 4 quarters · filed 2026-02-17
2024-09-30$14.70M
10-Q · filed 2025-11-14
$34.24M
derived: sum of 2 quarters · filed 2025-11-14
$34.36M
derived: sum of 3 quarters · filed 2025-11-14
$58.88M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$19.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26
$19.67M
derived: sum of 2 quarters · filed 2025-09-26
$44.18M
derived: sum of 3 quarters · filed 2025-09-26
$49.14M
10-K · filed 2025-09-26
2024-03-31$122.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13
$24.64M
derived: sum of 2 quarters · filed 2025-05-13
$29.60M
10-Q · filed 2025-05-13
$48.99M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$24.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12
$29.47M
10-Q · filed 2025-02-12
$48.87M
derived: sum of 3 quarters · filed 2025-02-12
$58.90M
derived: sum of 4 quarters · filed 2025-02-12
2023-09-30$4.96M
10-Q · filed 2024-11-12
$24.35M
derived: sum of 2 quarters · filed 2024-11-12
$34.38M
derived: sum of 3 quarters · filed 2024-11-12
$44.91M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$19.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19
$29.42M
derived: sum of 2 quarters · filed 2024-09-19
$39.95M
derived: sum of 3 quarters · filed 2024-09-19
$53.69M
10-K · filed 2024-09-19
2023-03-31$10.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-09
$20.56M
derived: sum of 2 quarters · filed 2024-05-09
$34.29M
10-Q · filed 2024-05-09
$54.41M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$10.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13
$24.27M
10-Q · filed 2024-02-13
$44.38M
derived: sum of 3 quarters · filed 2024-02-13
$59.54M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30$13.73M
10-Q · filed 2023-11-09
$33.85M
derived: sum of 2 quarters · filed 2023-11-09
$49.00M
derived: sum of 3 quarters · filed 2023-11-09
$5.63M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$20.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-26
$35.27M
derived: sum of 2 quarters · filed 2023-09-26
-$8.10M
derived: sum of 3 quarters · filed 2023-09-26
$6.89M
10-K · filed 2023-09-26
2022-03-31$15.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11
-$28.21M
derived: sum of 2 quarters · filed 2023-05-11
-$13.22M
10-Q · filed 2023-05-11
-$3.23M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$43.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-09
-$28.38M
10-Q · filed 2023-02-09
-$18.39M
derived: sum of 3 quarters · filed 2023-02-09
-$3.00M
derived: sum of 4 quarters · filed 2023-02-09
2021-09-30$14.99M
10-Q · filed 2022-11-14
$24.98M
derived: sum of 2 quarters · filed 2022-11-14
$40.37M
derived: sum of 3 quarters · filed 2022-11-14
$35.23M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$9.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08
$25.38M
derived: sum of 2 quarters · filed 2022-09-08
$20.23M
derived: sum of 3 quarters · filed 2022-09-08
$24.71M
10-K · filed 2022-09-08
2021-03-31$15.39M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-05-23
$10.24M
derived: sum of 2 quarters · filed 2022-05-23
$14.72M
10-Q · filed 2022-05-23
-$70.33M
derived: sum of 4 quarters · filed 2022-09-08
2020-12-31-$5.14M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-05-23
-$668.00K
10-Q/A · filed 2022-05-23
-$85.72M
derived: sum of 3 quarters · filed 2022-09-08
-$76.61M
derived: sum of 4 quarters · filed 2022-09-08
2020-09-30$4.48M
10-Q/A · filed 2022-05-23
-$80.57M
derived: sum of 2 quarters · filed 2022-09-08
-$71.47M
derived: sum of 3 quarters · filed 2022-09-08
-$106.78M
derived: sum of 4 quarters · filed 2022-09-08
2020-06-30-$85.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08
-$75.94M
derived: sum of 2 quarters · filed 2022-09-08
-$111.26M
derived: sum of 3 quarters · filed 2022-09-08
-$106.29M
10-K · filed 2022-09-08
2020-03-31$9.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06
-$26.21M
derived: sum of 2 quarters · filed 2021-05-06
-$21.25M
10-Q · filed 2021-05-06
-$11.29M
derived: sum of 4 quarters · filed 2022-05-23
2019-12-31-$35.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04
-$30.35M
10-Q · filed 2021-02-04
-$20.39M
derived: sum of 3 quarters · filed 2022-05-23
-$10.63M
derived: sum of 4 quarters · filed 2022-05-23
2019-09-30$4.97M
10-Q · filed 2020-11-10
$14.92M
derived: sum of 2 quarters · filed 2022-05-23
$24.69M
derived: sum of 3 quarters · filed 2022-05-23
$24.50M
derived: sum of 4 quarters · filed 2022-05-23
2019-06-30$9.96M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-23
$19.72M
derived: sum of 2 quarters · filed 2022-05-23
$19.53M
derived: sum of 3 quarters · filed 2022-05-23
$24.32M
10-K/A · filed 2022-05-23
2019-03-31$9.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07
$9.57M
derived: sum of 2 quarters · filed 2020-05-07
$14.36M
10-Q · filed 2020-05-07
-$45.07M
derived: sum of 4 quarters · filed 2020-09-09
2018-12-31-$193.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06
$4.59M
10-Q · filed 2020-02-06
-$54.84M
derived: sum of 3 quarters · filed 2020-09-09
-$49.74M
derived: sum of 4 quarters · filed 2020-09-09
2018-09-30$4.79M
10-Q · filed 2019-11-07
-$54.64M
derived: sum of 2 quarters · filed 2020-09-09
-$49.54M
derived: sum of 3 quarters · filed 2020-09-09
-$44.58M
derived: sum of 4 quarters · filed 2020-09-09
2018-06-30-$59.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09
-$54.33M
derived: sum of 2 quarters · filed 2020-09-09
-$49.37M
derived: sum of 3 quarters · filed 2020-09-09
-$44.33M
10-K · filed 2020-09-09
2018-03-31$5.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09
$10.06M
derived: sum of 2 quarters · filed 2019-05-09
$15.10M
10-Q · filed 2019-05-09
2017-12-31$4.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07
$10.01M
10-Q · filed 2019-02-07
2017-09-30$5.04M
10-Q · filed 2018-11-08
2017-06-30-$10.08M
10-K · filed 2019-08-28
2016-06-30$9.97M
10-K · filed 2018-08-30
2013-12-31-$20.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-11
-$20.01M
10-Q · filed 2014-02-11
-$20.02M
derived: sum of 3 quarters · filed 2014-02-11
-$20.04M
derived: sum of 4 quarters · filed 2014-02-11
-$20.09M
10-Q · filed 2014-02-11
2013-09-30-$6.00K
10-Q · filed 2013-11-08
-$16.00K
derived: sum of 2 quarters · filed 2013-11-08
-$40.00K
derived: sum of 3 quarters · filed 2013-11-08
-$42.00K
derived: sum of 4 quarters · filed 2014-02-11
-$95.00K
10-Q · filed 2013-11-08
2013-06-30-$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-18
-$34.00K
derived: sum of 2 quarters · filed 2013-09-18
-$36.00K
derived: sum of 3 quarters · filed 2014-02-11
-$38.00K
10-K · filed 2013-09-18
-$89.00K
10-K · filed 2013-09-18
2013-03-31-$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09
-$26.00K
derived: sum of 2 quarters · filed 2014-02-11
-$28.00K
10-Q · filed 2013-05-09
-$79.00K
10-Q · filed 2013-05-09
2012-12-31-$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-11
-$4.00K
10-Q · filed 2014-02-11
-$55.00K
10-Q · filed 2013-02-12
2012-09-30-$2.00K
10-Q · filed 2013-11-08
-$53.00K
10-Q · filed 2012-11-13
2012-06-30-$51.00K
10-K · filed 2012-09-18
2012-03-31-$51.00K
10-Q · filed 2012-05-15
2011-12-31-$51.00K
10-Q · filed 2012-02-09
2011-09-30-$51.00K
10-Q · filed 2011-11-14
2011-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-18
$0.00
derived: sum of 2 quarters · filed 2012-09-18
$0.00
derived: sum of 3 quarters · filed 2012-09-18
-$48.00K
10-K · filed 2012-09-18
2011-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15
$0.00
derived: sum of 2 quarters · filed 2012-05-15
-$48.00K
10-Q · filed 2012-05-15
2010-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09
-$48.00K
10-Q · filed 2012-02-09
2010-09-30-$48.00K
10-Q · filed 2011-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38